Our model was adapted from a study showing that BAPN and Ang II administration in C57Bl/6J mice without any specific genetic background develop 49% of AAA and 38% of TAA mostly in the ascending part of the aorta (23). The gene discussed is AGT; the disease is triple-A syndrome.